Join Next LSI Event

Join Now

LSI Europe '24 Summit

Filling Fast
LSI Europe '23 LSI Europe '23
EVENT SOLD OUT

LSI Europe '23

First Group of Presenting Companies Listed Below.

(Our pipeline of new company applications is filling and we're vetting them as fast as we can, so check back for regular updates. If you'd like to be considered as a presenter, please apply here now.)

Apply To Present
Teiimo

Teiimo establishes a new category of intelligent garments that capture vital parameters. The garment records data, analyzes it and makes the information accessible to the patient, his doctors and care takers. The company’s focus is on healthcare and medical applications. Teiimo’s technology allows for soft and comfortable integration of sensors into base layers such that the garment becomes a comfortable sensing device.

Visit website.

Markus Strecker
flag
Markus Strecker, CEO & Founder
Teiimo

In-Person Presenter
Dr. Jay

Real-time diagnostics and personalized treatment platform for mental health and well-being.

Visit website.

Anton Vorbev
flag
Anton Vorbev, CEO
Dr. Jay

booth icon Innovator Pavilion
STENTiT

STENTiT is focused on the development of regenerative endovascular implants. The company's technology will be bioresorbable and capable of activating the body's naturally healing response to restore diseased arteries from the inside-out. 

Visit website.

Bart Sanders
flag
Bart Sanders, CEO & Co-Founder
STENTiT

In-Person Presenter
AppMed

AppMed's APPY platform is a software solution that allows patients and their healthcare providers to optimize pharmacological treatment strategies for patients with ADHD. The solution computes and visualizes pharmacokinetic profiles of various drug combinations that maximize drug treatments in combination with routinely submitted patient-specific data to optimize patient care.

Visit website.

Louis-Paul Marin
flag
Louis-Paul Marin, President & Founder
AppMed

In-Person Presenter
Liva Healthcare

Liva Healthcare are digitizing personal healthcare. The company's digital health platform provides users with personalized coaching and tailored lifestyle plans. Currently the company offers digital programs for weight management and diabetes prevention.

Visit website.

Shahram Sharif
flag
Shahram Sharif, CEO
Liva Healthcare

In-Person Presenter
H2 Global Group

H2 Global is a pioneer in using molecular hydrogen in the fields of healthcare (including biotech and medtech), wellness, beauty, agriculture, and veterinary medicine. 

Visit website.

David Marsalek
flag
David Marsalek, President
H2 Global Group
Milan Krojicek
flag
Milan Krojicek, Vice President R&D & Manufacturing
H2 Global Group

In-Person Presenter booth icon Innovator Pavilion
Zedsen

Electrical Capacitance Tomography (ECT) uses electric fields to measure the permittivity of an object. When applied to a medical device, ECT can be used to identify cancers due to the increased permittivity seen as a result of cellular disarray that cancer causes. Zedsen is using this approach to develop a portable, non-invasive, and affordable solution to bring early cancer detection into the community clinic and general practitioners offices. 

Visit website.

Michael Lynch
flag
Michael Lynch, CEO
Zedsen

In-Person Presenter
Icarus Medical

Icarus Medical is harnessing 3D printing to bring patients personalized knee braces that more effectively reduce pain and improve function and movement activity. Using a 3D scan captured via a smartphone application, Icarus Medical produces custom braces in just two weeks to get patients comfortably ambulating. 

Visit website.

David Johnson
flag
David Johnson, CEO
Icarus Medical

booth icon Innovator Pavilion
Endospan

Endospan's Nexus is a minimally invasive solution designed to simplify aortic arch repair. The Nexus system consists of a modular arch stent graft, ascending stent graft, and a distal extension that is placed using a proprietary delivery system that provides stable anchoring and atraumatic sealing across a range of aortic pathologies. 

Visit website.

Kevin Mayberry
flag
Kevin Mayberry, CEO
Endospan

In-Person Presenter
Protembis

Silent brain infarcts occur in nearly all patients who undergo transcatheter aortic valve replacement. These stealth incidents lead to cognitive decline and significantly increase a patient's risk of future stroke. To combat this, Protembis are developing the ProtEmbo Cerebral Protection System. This catheter-based solution is deployed during leftsided heart procedures to deflect embolic material away from cerebrovascular circulation.

Visit website.

Karl von Mangoldt
flag
Karl von Mangoldt, CEO
Protembis

In-Person Presenter
Binx Health

binx health's point-of-care diagnostic solution, binx io, is an FDA-cleared, CLIA-waved platform intended to enhance community health outcomes through access to affordable and rapid testing results. The company's system utilizes ultra-rapid polymerase chain reaction (PCR) amplification to obtain results in approximately 30 minutes. binx's diagnostic tests are initially focused on providing men and women with rapid access to results for sexually transmitted infections (STIs).

Visit website.

Jeff Luber
flag
Jeff Luber, CEO
Binx Health

In-Person Presenter
The Shape Sensing Company

The Shape Sensing Company is seeking to take minimally invasive surgery into the next generation. Shape sensing technology utilizes fiber optic sensors to detect the shape and location of medical devices (e.g., catheters, endoscopes) within the body. The company's technology will minimize the complexity associated with traditional instrument navigating and tracking methods, such as fluoroscopy and ultrasound, while providing clinicians with comprehensive instrument tracking data.

Visit website.

Ryan DeBoer
flag
Ryan DeBoer, Vice President of Strategic Partnerships
The Shape Sensing Company

booth icon Innovator Pavilion
Neuroscience Innovative Technologies (Neurostech)

Neurostech exists at the crossroads of the medtech & pharmaceutical industry. The company is investigating innovative medtech and pharma products for the treatment of neurological conditions. Neurostech specializes in utilizing its knowledge of cerebrospinal fluid (CSF) dynamics and bioengineering to deliver drugs across the blood-brain barrier. The initial application for this platform drug delivery solution will be as a preventative treatment for Alzheimer's disease.

Visit website.

Rafael Permuy Martínez
flag
Rafael Permuy Martínez, Founder Partner & Chief Business Officer
Neuroscience Innovative Technologies (Neurostech)

In-Person Presenter
ABCDx

ABCDx is focused on the discovery, clinical validation and commercialization of a Software as Medical Device (SaMD) platform to evaluate cerebrovascular disorders. The BRAINCheck solution captures and analyzes brain biomarkers from a single drop of blood to triage stroke and traumatic brain injury (TBI) patients via a smartphone application. 

Visit website.

Jean-Charles Sanchez
flag
Jean-Charles Sanchez, CEO
ABCDx

In-Person Presenter
earAccess

earAccess strives to improve access to high-quality, cost-effective hearing aids. The company is on a social mission to improve access to hearing care, particularly in underserved communities and developing countries. The company offers a portfolio of hearing aids that are designed to endure drastic climates, from extreme cold and heat, to dust and humidity. 

Visit website.

Audra Renyi
flag
Audra Renyi, Founder & CEO
earAccess

In-Person Presenter
CathVision

CathVision's solution is a proprietary low-noise EP system that helps guide electrophysiologists during cardiac ablation procedures. The ECGenius System enhances signal quality, helping physicians identify, diagnose, and treat complex cardiac arrhythmias. CathVision's ECGenius is paired with CARDIALYTICS, a suite of proprietary AI-powered analytical tools that are intended to provide automated analyses of electrograms to support physicians and improve outcomes.

Visit website.

Mads Matthiesen
flag
Mads Matthiesen, CEO
CathVision

In-Person Presenter
Magneto Thrombectomy Solutions

Magneto Thrombectomy Solutions are evaluating innovative, catheter-based solutions to transform the way thrombi (clots) are retrieved. The company's technology is based on the understanding of the electric properties of clots, which allow the Magneto catheter to function as a magnet for clots. 

Visit website.

Benny Dilmoney
flag
Benny Dilmoney, CEO
Magneto Thrombectomy Solutions

In-Person Presenter
Choice

Choice have developed small, implantable, wirelessly controlled valves as a contraceptive. Placed in a short, outpatient procedure, without the need for surgery, Choice valves open or close the fallopian tubes. The Choice system does not contain active electronics, batteries, or active chemical components.

Visit website.

Leonie van de Kamer
flag
Leonie van de Kamer, Co-Founder
Choice

booth icon Innovator Pavilion
CloverLife

CloverLife is addressing some of the largest challenges in the increasing population of patients suffering from heart valve disease. The company is developing an innovative mechanical heart valve that will offer improved durability compared to existing valves, without the need for anticoagulant therapy. 

Visit website.

Diego Cheja
flag
Diego Cheja, Co-Founder
CloverLife

In-Person Presenter
Alphyn Biologics

Alphyn Biologics is developing therapies to treat common skin diseases. At the core of this approach is the company's Multi-Target Therapeutics (MTT) AB-101 platform. The AB-101 platform is currently being investigated for the treatment of atopic dermatitis. 

Visit website.

Neal Koller
flag
Neal Koller, CEO
Alphyn Biologics

In-Person Presenter
Opsin Biotherapeutics

Opsin Biotherapeutics is a joint venture that combines the expertise of Nanoscope Technologies with DesignPlex Biomedical to create unique products and alternatives to opioids and spinal cord stimulation for the treatment of chronic pain. Opsin's therapy specifically targets and activates the neurons that block pain through the delivery of light sensitive proteins that are activated via a low power LED light.

Visit website.

Robert Benkowski
flag
Robert Benkowski, CEO
Opsin Biotherapeutics

In-Person Presenter
Melodi Health

Melodi Health offers surgical solutions for the tens of thousands of women undergoing breast reconstruction each year. The company is developing an absorbable scaffold that is intended to provide support to soft tissue and reduce post-operative infections via the elution of antibiotics. 

Visit website.

Sarah Worrell
flag
Sarah Worrell, CEO
Melodi Health

In-Person Presenter
Senseye

Senseye is building a platform to support patients in managing their mental health. The Senseye mobile application uses computer vision to capture metrics from the eye. Data collected is analyzed by the company's machine learning algorithm to provide objective diagnosis and monitoring of mental health. The application is initially being developed for the diagnosis of post-traumatic stress disorder (PTSD).

Visit website.

David Zakariaie
flag
David Zakariaie, CEO/Founder
Senseye

In-Person Presenter
Vigor Medical

Vigor Medical is developing life-saving technologies and products for the treatment of chest trauma. Vigor's self-fixation sealing device, C-Lant, prevents the collapse of the heart and lung in cases of severe chest trauma. The C-Land device uses a proprietary self-fixation mechanism to hermetically seal any wound surface, provide immediate hemostasis, and create an accessible drainage shaft for the exchange of catheters.

Visit website.

Avi Hirsch
flag
Avi Hirsch, Director of Business Development
Vigor Medical

In-Person Presenter
Capri Medical

Capri-Medical seeks to change the way neuromodulation therapies are delivered. The company's injectable neurostimulation device will make this type of therapy more accessible for a number of indications. The technology is currently being evaluated for the treatment of chronic peripheral nerve pain.

Visit website.

Fergal Ward
flag
Fergal Ward, CEO
Capri Medical

In-Person Presenter
Angel Valve Vienna

Angel Valve Vienna (AVVie) is developing a novel, minimally invasive implant to address mitral valve regurgitation. The Mitral Butterfly implant features a unique, physiological design to facilitate the reconstruction of the mitral valve in cases of mitral valve prolapse. The device can be placed directly onto the diseased valve's leaflet in a one-step transcatheter procedure. 

Visit website.

Jozef Tanczos
flag
Jozef Tanczos, CSO
Angel Valve Vienna

In-Person Presenter
Annaida Technologies

Annaida Technologies vision is to transform the way microscopic life is measured, analyzed, and understood. The company's MRS (magnetic resonance spectroscopy) device is a non-invasive technology that looks at metabolic activity at the cellular level, providing new insights for the life sciences industry. Annaida's lead product, EmbryoSpin, detects and quantifies biomarkers to support Assisted Reproductive Therapies and improve embryo selection. The technology addresses many of the challenges and risks associated with current screening methodologies.  

Visit website.

Gaurasundar Conley
flag
Gaurasundar Conley, CEO
Annaida Technologies

In-Person Presenter
BrightHeart

BrightHeart is developing an artificial intelligence (AI) software company focused on improving the detection of congenital heart defects from fetal ultrasounds. Leveraging a proprietary database of 20,000 ultrasound exams, BrightHeart's AI and expertise in fetal ultrasound cardiac imaging helps improve caregivers' detection of complex heart defects in utero, during an ultrasound exam, when early interventions could correct or improve a child's chance of survival.

Visit website.

Cecile Dupont
flag
Cecile Dupont, CEO
BrightHeart

In-Person Presenter
ViCentra

ViCentra's Kaleido device is a new insulin delivery system designed to give patients with diabetes freedom and peace of mind, with a focus on device customization. The system combines a handset with a micro-pulse delivery system that can be customized to be worn how patients to use choose.

Visit website.

Frans Cromme
flag
Frans Cromme, CEO
ViCentra

In-Person Presenter
Caresyntax

Caresytnax's vendor-neutral, enterprise-grade digital surgery platform is designed to help multiple stakeholders improve care delivery. Using artificial intelligence and big data, the platform is enabling healthcare providers to improve the quality of care inside and outside of the operating room.

Visit website.

Claire Masterson
flag
Claire Masterson, CFO
Caresyntax

In-Person Presenter
ReGelTec

ReGelTec, Inc. is a clinical stage medical device company developing the next generation of interventional spinal implants for chronic lower back pain due to degenerative disc disease. Hydrafil is a Injectable hydrogel for Degenerative Disc Disease the procedure has a very short recovery time 1-2 hrs post injection with early clinical results showing significant improvement in back pain and ODI scores.

Visit website.

Bill Niland
flag
Bill Niland, CEO
ReGelTec

In-Person Presenter
NuVision Biotherapies

NuVision Biotherapies is a biotechnology company seeking to develop cost-effective and high-quality regenerative therapies for ophthalmology. The company's lead product, Omnigen, is a natural wound dressing and grafting material used to aid the natural healing process of the eye in cases of soft tissue damage.

Visit website.

Andy Hill
flag
Andy Hill, CEO
NuVision Biotherapies

In-Person Presenter
Galen Robotics

Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures. 

Visit website.

Bruce Lichorowic
flag
Bruce Lichorowic, CEO
Galen Robotics

In-Person Presenter
MY01

MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.

Visit website.

Charles Allan
flag
Charles Allan, CEO
MY01

In-Person Presenter
Caira Surgical

Caira® Surgical is pioneering the development of radar-based surgical tracking, rapid landmark registration, and other leading-edge technologies to revolutionize usability, economics, and access to advanced surgical navigation and robotics for orthopedic surgery. The company's first product is Radar Surgical Navigation™ for Total Knee Replacement. Caira's proprietary sub-millimeter-accurate Radar Surgical Tracking for navigated and robotic procedures eliminates line-of-sight interference, invasive bone pins, and multiple incisions inherent in existing surgical tracking systems. Our technology enables a simple workflow and significantly reduces operative time, complexity, and cost. We develop solutions that improve patient outcomes and eliminate adoption barriers to improve access to cutting-edge technology for surgeons, patients, outpatient surgery centers, and hospitals worldwide.

Visit website.

Jon Greenwald
flag
Jon Greenwald, CEO
Caira Surgical

In-Person Presenter
ReddyPort

Non-invasive ventilation (NIV) is a first line therapy in patients presenting with respiratory insufficiency or failure, as well as in patients coming off mechanical ventilation. There are many challenges associated with the NIV masks that reduce patient QoL and can lead to poor outcomes. ReddyPort is developing products to address these challenges and improve NIV success via an innovative elbow that features a self-sealing valve that provides access to the patient's mouth to facilitate cleaning and moisturizing the patient's mouth without disrupting therapy.

Visit website.

Branden Rosenhan
flag
Branden Rosenhan, Co-Founder and Board of Directors
ReddyPort

In-Person Presenter
Picard Medical (SynCardia Systems)

Picard Medical is the parent company of SynCardia, a developer of mechanical heart replacement technologies for patients suffering from end-stage heart failure. SynCardia develops and commercializes an FDA-approved temporary Total Artificial Heart (TAH). The implantable TAH system is designed to assume all the functions of a failing human heart in transplant-eligible patients at risk of imminent death from biventricular failure.

Visit website.

Daniel Teo
flag
Daniel Teo, Executive Director
Picard Medical (SynCardia Systems)

In-Person Presenter booth icon Innovator Pavilion
ProArc Medical

Tens of millions of men worldwide experience symptoms of benign prostate hyperplasia (BPH). The Omega device by ProArc Medical is a minimally invasive, non-surgical procedure to restore urinary function and treat lower urinary tract symptoms (LUTS) caused by an enlarged prostate.

Visit website.

Gilad Hizkiyahu
flag
Gilad Hizkiyahu, CEO
ProArc Medical

In-Person Presenter
AccurKardia

AccurKardia is an ECG-led diagnostics company. We are unlocking the value of the ECG signal towards broad diagnostics coverage and disease management in cardiology and beyond. This holds the key to improving clinical outcomes and saving lives at a planetary scale.

AccurKardia's first product, AccurECG is an FDA cleared, cloud-based, and device agnostic software for fully automated ECG interpretation and arrhythmia diagnosis for up to 13 arrhythmias. It is intended to assist cardiac monitoring companies in the analysis of ECGs recorded from holters, event recorders and cardiac telemetry devices.

The Company completed Cohort 3 of Mayo Clinic Platform_Accelerate in July 2023.  

Visit website.

Mohamed Sadeq Ali
flag
Mohamed Sadeq Ali, Co-founder and COO
AccurKardia

In-Person Presenter
Tulavi Therapeutics

Nerve repair technology is long due for an advancement beyond current interventional options. Tulavi Therapeutics is working to provide a higher standard of care when it comes to nerve care. The company is engineering simple, OR-based solutions to proactively prevent nerve pain and promote nerve regeneration, with an initial focus on treating the nerves of limbs.

Visit website.

Corinne Bright
flag
Corinne Bright, CEO
Tulavi Therapeutics

In-Person Presenter
Sinaptica

Sinaptica Therapeutics is a clinical-stage company that is developing a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease. The company’s SinaptiStim System represents a totally new approach to treating AD by enhancing neuroplasticity via noninvasive neurostimulation of key brain networks involved in memory. The therapy has been clinically demonstrated to slow the progression of cognitive decline and functional decline in patients with mild-to-moderate Alzheimer's disease. 

Visit website.

Ken Mariash
flag
Ken Mariash, CEO
Sinaptica

In-Person Presenter
Implandata Ophthalmic Products

The eyemate system from Implandata Ophthalmic Products is an eye pressure measurement system for patients with glaucoma. The digital health solution enables improved therapeutic guidance and protection of eyesight for glaucoma patients. The system consists of an implantable microsensor that communicates with hand-held devices. eyemate provides real time information regarding the effectiveness and therapy and disease status.

Visit website.

Max Ostermeier
flag
Max Ostermeier, CEO & Founder
Implandata Ophthalmic Products

In-Person Presenter
AtriAN Medical

Long-term, non-thermal resolution of atrial fibrillation. AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF). This non-thermal approach targets hyperactive cell structures on the outside of the heart and disrupts the errent electrical signals that are responsible for AF, while sparing healthy tissue.

Visit website.

Ken Coffey
flag
Ken Coffey, CEO
AtriAN Medical

In-Person Presenter
NOxy Health Products

NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative capabilities of nitric oxide (NO) to heal chronic wounds. Due to various factors, the body can lack the natural ability to produce and deliver sufficient NO. The company is investigating topical means to deliver NO exogenously to improve oxygen and nutrient flow to wounds, promote healthy inflammation, and stimulate the development of new microvessels and tissue.

Visit website.

Tim Jacobson
flag
Tim Jacobson, CEO
NOxy Health Products

In-Person Presenter
Indigo

Indigo is providing an answer to the need for accurate and accessible chronic disease management solutions. The company is using nanophotonics in its continuous multi-metabolite monitoring (CMM) sensor. This small sensor measures the absorption of light in the interstitial fluid to quantify concentrations of multiple metabolites without the use of enzymes or fluorophores. 

Visit website.

Danaë Delbeke
flag
Danaë Delbeke, Founder & CEO
Indigo

In-Person Presenter
I-VASC

Founded in 2015, I-VASC is focused on bringing its Empty Vein Ablation (EVA) technology for the treatment of varicose veins to the global market. The Velex system is a minimally invasive, nonthermal and non-tumescent device for sclerotherapy. Featuring an innovative 3 balloon design, the Velex system removes blood from the diseased vessel to improve the effectiveness of the injected chemically ablative drug. 

Visit website.

Cristiano Fontana
flag
Cristiano Fontana, Board Member- Head of Business Development
I-VASC

In-Person Presenter
RECORNEA

Keratoconus is a progressive eye disease of the cornea the leads to distorted vision and poor quality. RECORNEA's GROSSO implant restores the physiological curvature of the cornea and halts progression of the disease. 

Visit website.

Emiliano Lepore
flag
Emiliano Lepore, Co-founder, CEO and Chairman
RECORNEA

In-Person Presenter
Insight Surgery

Insight Surgery provides digital planning and point-of-care surgical guides for all surgical disciplines. The company offers an extensive range of products and services intended to improve patient outcomes and optimize operational expenses. 

Visit website.

Henry Pinchbeck
flag
Henry Pinchbeck, CEO
Insight Surgery

In-Person Presenter
Robopedics

Robopedics' Awake is a robotic orthopedic solution specifically for stroke victims. Awake has been designed specifically for the rehabilitation of hemiplegia and hemiparesis due to stroke. The device is an alternative to exoskeletons, being more accessible and ergonomic means to help stroke patients return home, improve their quality of life, and ultimately be able to walk on their own.

Visit website.

Iván Martínez
flag
Iván Martínez, CEO & Founder
Robopedics

In-Person Presenter
Eversens

everSens specializes in the design, development, and manufacture of solutions for the analysis of human respiration. The company's Evernoa Base measures the fraction of exhaled nitric oxide (FeNO) present in the human breath to noninvasively detect exhaled biomarkers to disease inflammatory respiratory diseases, such as asthma. 

Visit website.

Leyre Ruete Ibarrola
flag
Leyre Ruete Ibarrola, CEO
Eversens

In-Person Presenter
CYTO365

CYTO365 is looking to change the way infusion therapy is delivered. The company's RondelO stopcock manifold effectively prevents accidental, and potentially life-threatening, drug mixing in patients. The device provides an extra-layer of security that clearly indicates which drug is active to healthcare providers while also offering an integrated flushing that separates drugs from mixing down the line.

Visit website.

Micael Toernblom
flag
Micael Toernblom, CEO
CYTO365

In-Person Presenter
3dthinks

3dthinks is developing solutions for individuals with disabilities that limit how they can function in the world. The company's proficiencies in additive manufacturing (3D printing) and digital technologies are creating new solutions for patients with disabilities that limit their independence. From innovative solutions using smartphone apps and AR to improve communication to a mounted communication device that gives wheelchair-bound individuals the freedom to drive without assistance – 3dthinks seeks to improve lives with affordable innovations.

Visit website.

Jaume Sanchez
flag
Jaume Sanchez, CEO
3dthinks

In-Person Presenter
IQ Endoscopes

At IQ Endoscopes, we are creating pioneering, sustainable endoscopy technologies for the early diagnosis of diseases, helping to create a world where everyone has access to sustainable sterile endoscopy. Our Single Use Gastroscope is currently under regulatory review and this will be quickly followed by regulatory submissions for our single use colonoscope and sigmoidoscope in 2024. This compelling platform will enable IQ Endoscopes to offer healthcare professionals the most comprehensive range of single use technology to address the Gastro Intestinal market, whilst also ensuring key sustainability requirements are surpassed. With commercial activities set to begin in 2025, the organization is at a very exciting stage.

Visit website.

Matt Ginn
flag
Matt Ginn, CEO
IQ Endoscopes

In-Person Presenter
Rethink Medical

Rethink Medical is focused on developing novel medical devices, based on nursing experience. Its T-Control catheter, through an in-built fluid controlling valve, addresses currently unmet needs related to conventional catheters. It improves patients' quality of life, prevents infections and enhances the work efficiency of the healthcare staff, generating savings to the healthcare system too.

Visit website.

Szilvia Endrenyi
flag
Szilvia Endrenyi, CEO & Co-founder
Rethink Medical

In-Person Presenter
PreciHealth

PreciHealth is committed towards enabling individuals to easily and safely self-administer medication and collect diagnostic blood samples from the comfort of their home. With a focus on the use of innovative micromechanics and microfluidics, the company is developing a portfolio of auto injectors (i.e., drug delivery) and blood collection devices.

Visit website.

Laurence Blazianu
flag
Laurence Blazianu, CFO
PreciHealth

In-Person Presenter
Vivasure Medical

Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).

Visit website.

Andrew Glass
flag
Andrew Glass, CEO
Vivasure Medical

In-Person Presenter
Alesi Surgical

Alesi Surgical's Ultravision system utilizes the process of electrostatic precipitation to eliminate surgical smoke that accumulates during laparoscopic surgery. The device maintains a continuously clear visual field without the need for CO2. The Ultravision system has been evaluated in a range of procedures, from gastrointestinal, gynecological, urological and in robotic-assisted laparoscopic procedures. 

Visit website.

Dominic Griffiths
flag
Dominic Griffiths, CEO
Alesi Surgical

In-Person Presenter
Echopoint Medical

Echopoint Medical is developing a family of optical-fiber based sensors which integrate into microcatheters to guide and improve outcomes during interventional cardiology procedures. The company's iKor platform translates ultrasonic signals to measure blood pressure and flow to more accurately assess, diagnose and treat patients with coronary artery disease and coronary microvascular dysfunction. 

Visit website.

Antony Odell
flag
Antony Odell, CEO
Echopoint Medical

In-Person Presenter
Adtec Healthcare

Adtec Healthcare are specialists in energy-based technologies. Cold plasma, which is electron dense, charged, ionized gas, that is safe to the touch has many different applications in healthcare. Adtech is commercializing a cold plasma solution, SteriPlas, for infection control applications. The use of cold plasma has been clinically proven to effectively treat biofilms, wounds, surgical site infections, and bacterial skin conditions as an alternative to antibiotics.

Visit website.

Mary McGovern
flag
Mary McGovern, Managing Director
Adtec Healthcare

In-Person Presenter
TendoMend

TendoMend's Dynamic Tendon Grip surgical device that replaces the traditional, time-consuming techniques currently used for the repair of ruptured tendons. The Dynamic Tendon Grip consists of a low-profile implant and a dedicated applicator that creates a grip akin to the original tendon profile while simultaneously improving suture connection strength. With an initial focus on hand tendon laceration, TendoMend plans to modify their platform technology for use in the repair of Achilles, bicep, quadricep & patella tendon ruptures. 

Visit website.

Ehud Almon
flag
Ehud Almon, CEO
TendoMend

In-Person Presenter
Pacertool

Pacertool develops PaCRTool, a solution to improve cardiac resynchronization therapy (CRT) in heart failure patients. PaCRTool provides healthcare professionals with quantifiable evidence to determine when CRT is effectively applied to heart failure patients and ensure synergy from biventricular pacing. The system also functions as a simple electrophysiology system for AV node ablations and PES. 

Visit website.

Jon Hoem
flag
Jon Hoem, CEO
Pacertool

In-Person Presenter
UpSurgeOn

UpSurgeOn's mission is to fill the gap between theory and practice in surgery via psychomotor skill augmentation. To achieve this, the company has developed a mixed reality digital platform that combines smartphone applications, augmented & virtual reality, and physical simulators to improve surgical training. UpSurgeOn is currently focused on the development of surgical simulator courses for neurosurgical skills.

Visit website.

Federico Nicolosi
flag
Federico Nicolosi, Founder & CEO
UpSurgeOn

In-Person Presenter
Bloomlife

Bloomlife is focused on building out its commercialization efforts for its first product, a smart pregnancy wearable that automatically detects and tracks contractions which expectant moms can visualize on their smartphone. With their innovative technology, Bloomlife allows the expectant mom to better understand her body and gain peace of mind throughout the third trimester. 

Visit website.

Julien Penders
flag
Julien Penders, Co-founder & COO
Bloomlife

In-Person Presenter
NGMedical

NGMedical specializes in the development of implant-based solutions for spine surgery. The company is focused on motion preserving implants and intelligent solutions for spine fusion surgery. 

Visit website.

Peter Weiland
flag
Peter Weiland, CEO
NGMedical

In-Person Presenter booth icon Innovator Pavilion
Nirtek

Nirtek has created a patented device that utilizes near infrared light to evaluate intracoronary plaque. When the light is directed at unstable plaques an autofluorescence signal is detected by the device to indicate which diseased vessels require interventional therapy. The NIRAF device fits into the current coronary angiogram workflow while providing clinicians with new insights into unstable plaque that could progress to heart attack.

Visit website.

Matthew Hoskin
flag
Matthew Hoskin, CEO
Nirtek

In-Person Presenter
Conavi Medical

Conavi Medical is a commercial-stage medical device company. Its flagship product is the Novasight Hybrid system, a unique coronary imaging system that combines co-registered ultrasound (IVUS) and optics (OCT). Conavi is looking to further expand its base of clinical evidence for the 510(k)-cleared Novasight System and ready the system for broad market adoption.

Visit website.

Tom Looby
flag
Tom Looby, CEO
Conavi Medical

In-Person Presenter
TAE Life Sciences

TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods. 

Visit website.

Rob Hill
flag
Rob Hill, CEO
TAE Life Sciences

In-Person Presenter
Opto Biosystems

Opto Biosystems seeks to transform the way patients with neurological disorders are treated. The company is focused on the emerging field of bioelectronics to develop wirelessly powered sensors to diagnose and treat serious neurological conditions from epilepsy to brain cancer. 

Visit website.

Ben Woodington
flag
Ben Woodington, Founder & CEO
Opto Biosystems

In-Person Presenter
MedLumics

MedLumics is developing a real-time, optical coherence tomography (OCT) guided ablation catheter. The PulseView system combines radiofrequency ablation and pulsed-field ablation to treat atrial fibrillation. The technology can directly assess lesion creation, providing physicians with confidence regarding the continuity and transmurality of the lesion and improving treatment durability. 

Visit website.

James Greene
flag
James Greene, CEO
MedLumics

In-Person Presenter
MedSniper

medSniper is a single-use video laryngoscope that features a steerable tip that is intended to improve airway visualization and management. 

Visit website.

Andrea Mazza
flag
Andrea Mazza, CEO
MedSniper

In-Person Presenter
Synergia Medical

Leveraging photonics to create a platform for small, safe and long-lasting neurostimulators.

Visit website.

Attila Borbath
flag
Attila Borbath, CEO
Synergia Medical

In-Person Presenter
OncoHost

OncoHost aims to help providers and patients understand a patient's unique response to cancer therapies. The PROphet platform combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide clinicians with actional clinical insights to optimize patient therapy. 

Visit website.

Ofer Sharon
flag
Ofer Sharon, CEO
OncoHost

In-Person Presenter
Mirai Medical

Mirai Medical ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment. 

Visit website.

Declan Soden
flag
Declan Soden, CEO
Mirai Medical

In-Person Presenter
Pristine Surgical

Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.

Visit website.

Bryan Lord
flag
Bryan Lord, CEO
Pristine Surgical

In-Person Presenter
SmartWound

SmartWound allows objective diagnosis of the Critical Infection Threshold in under 15 minutes and can therefore differentiate patients with infected wounds from those without an infection.

Visit website.

Philip Brown
flag
Philip Brown, Director
SmartWound

In-Person Presenter
Open Stent Solution

Open Stent Solution are pioneering a novel approach for the treatment of mitral valve regurgitation. The company is developing a unique transcatheter heart valve that is supported by a ribbon-shaped stent structure which overcomes the challenges associated with conventional cylindrical stents. OSS seeks to overcome the anatomical constraints that make transcatheter mitral valve delivery and implantation challenging with its unique technology.

visit website.

Doron Carmi
flag
Doron Carmi, President & CEO
Open Stent Solution

In-Person Presenter
Rob Surgical Systems

Rob Surgical is developing a surgical robotic system for minimally invasive surgery. The Bitrack System is an open robotic system designed to support a large scope of abdominal and pelvic surgical procedures. The system's unique robotic column architecture provides multi-quadrant surgical access to enable four-quadrant anatomical access and complete patient accessibility.  

Visit website.

Jaume Amat
flag
Jaume Amat, Founder & CEO
Rob Surgical Systems

In-Person Presenter
Sonic Incytes

Sonic Incytes' Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types. Scans using the Velacur system can be performed in the physician office in approximately 5 minutes, producing real-time measurements of liver stiffness and attenuation. 

Visit website.

Barry Allen
flag
Barry Allen, President & CEO
Sonic Incytes

In-Person Presenter
AMT Medical BV

Coronary artery disease (CAD) is society's biggest killer. When not proactively managed, the disease requires costly surgical interventions that can carry post-surgical risks to patients. AMT Medical has developed a suture-less medical device that makes open-heart surgery less complex for interventionists and safer for patients. To-date, the company's patented solution has been successfully utilized in 10 patients in a first-in-human trial.

VIsit website.

Idgar van Kippersluis
flag
Idgar van Kippersluis, CFO
AMT Medical BV

In-Person Presenter
SmartCardia

SmartCardia's 7L Patch is a wearable 7-lead electrocardiogram (ECG) patch for cardiology and remote patient monitoring. The wearable enables real-time monitoring and detection of cardiac arrhythmias and is enhanced by the addition of machine learning software to enhance the detection of arrhythmic events and patient deterioration. 

 

Visit website.

Srinivasan Murali
flag
Srinivasan Murali, CEO
SmartCardia

In-Person Presenter
Scalpel

Scalpel's digital platform has been designed to address key challenges and improve the operation of the operation room. Using artificial intelligence (AI) and noninvasive sensors, Scalpel helps hospitals and providers manage inventory, optimize instrument trays, and provide detailed peri-operative data analytics.

Visit website.

Yeshwanth Pulijala
flag
Yeshwanth Pulijala, CEO
Scalpel

In-Person Presenter
Happitech

Happitech has developed a CE-marked, smartphone-based method for effective remote monitoring of patients. The company's core competencies in artificial intelligence (AI) integration and photoplethysmography (PPG) enable effective and accurate measurement of heart rate and atrial fibrillation.

Visit website.

Yosef Safi Harb
flag
Yosef Safi Harb, Founder & CEO
Happitech

In-Person Presenter
Ostoform

Ostoform's mission is to improve skin health and quality of life in people living with an ostomy. The company's Ostoform device prevents and protects the seal adhesive from the output of the ileostomy leaking onto the patient's skin, keeping skin healthy and giving the patient confidence, while simultaneously directing output into the ostomy pouch. 

Visit website.

Kevin Kelleher
flag
Kevin Kelleher, CEO
Ostoform

booth icon Innovator Pavilion
Wander Health

Wander Health's digital platform is designed to connect travelers with English-speaking healthcare providers across the globe. The company's digital medical concierge platform facilitates healthcare utilization in foreign countries for primary and urgent care needs. 

Visit website.

Dana Le
flag
Dana Le, CEO & Founder
Wander Health

In-Person Presenter
Approxima

Approxima is an early-stage medtech startup developing a minimally invasive solution for tricuspid valve repair. The device is based on a right ventricular reshaping approach to treat patients with tricuspid regurgitation. 

Visit website.

Michal Jaworek
flag
Michal Jaworek, CEO & Co-Founder
Approxima

In-Person Presenter
DIP235

DIP235 believes that physics can be used to fight cancer by impacting biology and immunology as a whole, thereby drastically improving treatment. The company is developing a unique technology for targeted, physics-based cancer therapy. The technology utilizes electromagnetic waves and pulsed microwaves in a vacuum chamber to create plasmas that are further stimulated by powerful pulsed electromagnetic fields (PEMF).

Visit website.

Paul Derly
flag
Paul Derly, Partner
DIP235
Yves Dubreuil
flag
Yves Dubreuil, CEO & Founder
DIP235
Dr Jorge Enrique Diaz
flag
Dr Jorge Enrique Diaz, CMO
DIP235

booth icon Innovator Pavilion
SamanTree Medical

SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory. 

Visit website.

Olivier Delporte
flag
Olivier Delporte, CEO
SamanTree Medical

In-Person Presenter
Quibim

Quibim is using artificial intelligence to unlock new insights from medical images. The company's SaaS platform harnesses AI techniques to obtain digital biomarkers and new data from CT, MRI, and PET images. The platform is a "one-stop-shop" that handles, integrates, stores and processes multi-omics data with imaging that enhances patient care and optimizes drug development programs.

Visit website.

Angel Alberich-Bayarri
flag
Angel Alberich-Bayarri, CEO
Quibim

In-Person Presenter
Levita Magnetics

The Levita Magnetic Surgical System is an innovative technological platform that utilizes magnetic retraction designed to grasp and retract tissue and organs in laparoscopic cholecystectomy procedures to facilitate access and visualization of the surgical site. Levita Magnetic has implemented this technology into a robotic platform to assist in the performance of laparoscopic surgeries.

Visit website.

Alberto Rodriguez
flag
Alberto Rodriguez, CEO
Levita Magnetics

In-Person Presenter
Vektor Medical

Vektor Medical's vMAP system helps identify the sources of stable and unstable arrhythmia using accessible, noninvasive electrocardiogram (ECG) data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The FDA-cleared  vMAP system is capable of creating a "heat map" of the heart in < 3 minutes to support or improve ablation treatment planning.

Visit website.

Rob Krummen
flag
Rob Krummen, CEO
Vektor Medical

In-Person Presenter
THERYQ

THERYQ specializes in the design and production of linear accelerators for radiotherapy. The company's FLASH technology is intended to increase the effectiveness of radiotherapy, by taking the conventional radiotherapy process requiring multiple treatment sessions and weeks of irradiation and condensing it into a single procedure performed in milliseconds. The result of this high energy radiotherapy is a reduction in the side effects while simultaneously increasing treatment efficacy.

Visit website.

Ludovic Le Meunier
flag
Ludovic Le Meunier, CEO
THERYQ

In-Person Presenter
XEOS

XEOS is focused on improving outcomes in surgical oncology by leveraging the power of molecular imaging in the operating roomThe company’s AURA 10 specimen PET-CT imager provides surgeons with an immediate 3-dimensional visualization of the resected tissue specimen at the point of surgery. This information helps the surgeon ensure that a complete resection is obtained.

Visit website.

Vincent Keereman
flag
Vincent Keereman, Founder & CMO
XEOS

In-Person Presenter
Neuromod

Neuromod Devices is a medtech company focused on utilizing bimodal neuromodulation to treat chronic neurological conditions. The lead application for the company's technology is the Lenire device for the treatment of tinnitus. The Lenire solution is combines synchronized stimulation of the auditory nerve and nerves of the tongue to soothe and relieve tinnitus.

Visit website.

Ross O'Neill
flag
Ross O'Neill, Founder & CEO
Neuromod

In-Person Presenter
Hy2Care

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage. 

Visit website.

Leo Smit
flag
Leo Smit, CEO
Hy2Care

In-Person Presenter
Body Vision Medical

Body Vision's fusion imaging platform enables pulmonologists, for the first time, to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The Body Vision System, together with a unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early-stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics.

Visit website.

David Webster
flag
David Webster, CEO
Body Vision Medical

In-Person Presenter
IntraCross Catheter

Shuttle Catheter's technology addresses an unmet need in minimally invasive procedures. The company is developing an innovative catheter solution that enables minimally invasive procedures for crossing through severe arterial stenosis, plugging arterial ruptures, and preventing gastric reflux complications. 

Visit website.

Mihalis Boutaris
flag
Mihalis Boutaris, Co-Founder & CEO
IntraCross Catheter

In-Person Presenter
CardiaCare

CardiaCare is developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation. The wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.

Visit website.

Ofer Halbreich
flag
Ofer Halbreich, CEO
CardiaCare

In-Person Presenter
Acorai

Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality.

Visit website.

Filip Peters
flag
Filip Peters, CEO
Acorai

In-Person Presenter
Cardiac Success

Cardiac Success is committed to providing a new solution for the millions of patients who continue to suffer and deteriorate from heart failure with reduced ejection fraction. The V-sling is a transcatheter ventricular repair device that is designed to treat left ventricular dysfunction by repositioning the papillary muscles and restoring the conical shape of the left ventricle for improved cardiac function. 

Visit website.

Boaz Manash
flag
Boaz Manash, CEO
Cardiac Success

In-Person Presenter
Innotech Precision Medical

InnoTech Precision Medicine's mission is to bring high-performance diagnostics into the point-of-care. The company's diagnostic technology is based on the multi-modal and simultaneous detection of multiple classes of disease biomarkers from a single test to support accurate and early disease detection. The InnoTech Recognize test is a minimally equipped device that uses synthetic molecular biosensors to target multiple types of biomarkers that would traditionally require separate RT-PCR and antibody/antigen tests to detect multiple diseases. 

Visit website.

Roya Khosravi-Far
flag
Roya Khosravi-Far, President & CEO
Innotech Precision Medical

In-Person Presenter
Centerline Biomedical

A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

Visit website.

Gulam Khan
flag
Gulam Khan, CEO
Centerline Biomedical

In-Person Presenter
Tympany Medical

Tympany Medical is developing a next-gen endoscope for sinus surgery - Solascope. The device features sterile panoramic, lens-cleaning technology intended to reduce the number of scopes and time required to perform endoscopic procedures. The company is focused on circular manufacturing utilizing reusable and recyclable components that reduce environmental impact.

Visit website.

Liz McGloughlin
flag
Liz McGloughlin, CEO
Tympany Medical

In-Person Presenter
MiWEndo Solutions

Colorectal cancer is highly preventable when polyps are identified during routine screening procedures, however, over 20% of polyps are missed due to visual limitations of colonoscopes. MiWendo is developing a novel solution that attaches to conventional colonoscopes to increase field-of-view and differentiate between malignant and benign polyps. The accessory uses non-ionizing electromagnetic energy to sense and differentiate polyps, without changing the current clinical practice for colonoscopy.

Visit website.

Ignasi Belda
flag
Ignasi Belda, CEO
MiWEndo Solutions

In-Person Presenter
EP Solutions

EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits.

Visit website.

Matthias Egger
flag
Matthias Egger, COO
EP Solutions

In-Person Presenter
Sedivention

Sedivention aims to transform the way obesity is treated. The company is developing a gastric balloon equipped with cryoablative technology to freeze the gastric nerves inside of the stomach in a short procedure similar to gastroscopy. The technology is being evaluated as a means of turning off the "hunger nerves" to help patients realize improvements in weight management and diabetes control.

Visit website.

André Burch
flag
André Burch, Co-Founder & CEO
Sedivention

In-Person Presenter
PanTher Therapeutics

PanTher Therapeutics is a privately-held oncology company with a proprietary treatment platform for solid tumors. PanTher's Sagittari platform merges minimally invasive, surgically implant devices with chemotherapeutic agents to deliver targeted drug to the tumoral area. The technology bypasses the limitations associated with traditional chemotherapy routes of administration, while maximizing local effectiveness. The Sagitarri platform is initially being evaluated for the treatment of pancreatic cancer.

Visit website.

Laura Indolfi
flag
Laura Indolfi, CEO
PanTher Therapeutics

In-Person Presenter
Intelligent Implants

Intelligent Implants is working on the future of electrotherapeutic orthopedic devices. The company's mission is to develop a portfolio of smart, cloud-connected implants that can accelerate, control, and remotely monitor bone growth. Intelligent Implant's lead product is the SmartFuse System, which combines the company's proprietary electrotherapeutic technology platform with an intervertebral spacer to improve outcomes in lumbar spinal fusion procedures.

Visit website.

Ben Hertzog
flag
Ben Hertzog, CEO
Intelligent Implants

In-Person Presenter
Canary Medical

Canary Medical is giving a "voice" to implantable medical devices through the use of proprietary integrative sensor technology. The company's canturio platform creates new opportunities to improve patient outcomes and lower the cost of care through the generation of relevant data from implanted medical devices. Canary's lead product, the canturio te, is a modified tibial extension for use with Zimmer Biomet's Persona prosthetic knee joint that captures patient activity data that helps manage prosthetic knee post-surgical recovery.

Visit website.

Bill Hunter
flag
Bill Hunter, President & CEO
Canary Medical

In-Person Presenter
Kent Imaging

Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care.

Visit website.

Pierre Lemire
flag
Pierre Lemire, CEO
Kent Imaging

In-Person Presenter booth icon Innovator Pavilion
ScreenPoint Medical

ScreenPoint Medical's Transpara is an artificial intelligence (AI) solution to enhance early breast cancer detection and diagnosis. At the core of Transpara is FusionAI, a proprietary platform that merges pathology, clinical imaging, deep learning techniques, and X-ray physics. The software fits into existing workflows, providing radiologists with decision support that improve clinical accuracy, optimize workflow, and reduce workload. 

Visit website.

Mark Koeniguer
flag
Mark Koeniguer, CEO
ScreenPoint Medical

In-Person Presenter booth icon Innovator Pavilion
Nano4Imaging

Nano4Imaging has developed an magnetic resonance (MR) compatible guidewire to transfer select cardiovascular procedures from the cathlab to the MRI suite. Initially focused on developing their solutions for congenital heart diseases, the company plans to expand their technology into interventional procedures, such as angioplasty.

Visit website.

Rudolf Schulze Vohren
flag
Rudolf Schulze Vohren, CEO
Nano4Imaging

booth icon Innovator Pavilion
Aqua Heart

Aqua Heart is developing an over-the-wire, single shot ablation solution for the treatment of atrial fibrillation (AFib). The technology combines radiofrequency and balloon elements to bring familiar thermal ablation via a new technique that is a safe and fast way to perform pulmonary vein isolation.

Visit website.

Holger Friedrich
flag
Holger Friedrich, CEO
Aqua Heart

In-Person Presenter
Fluid Biomed

Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Our innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. Backed by years of laboratory research, a strong IP and tech transfer position, and contract manufacturing partners, the company is opening a $10M Series A round to launch human clinical trials.

Visit website.

John Wong
flag
John Wong, CEO
Fluid Biomed

In-Person Presenter
GreenBone Ortho

GreenBone Ortho develops and commercializes patented, innovative, wood-derived bone regenerative implants for bone reconstruction. The company's technology transforms wood into a mixture of hydroxyapatite (HA) and beta-tricalcium phosphate (TCP) to produce a porous structure similar to normal healthy bone. GreenBone's b. Bone implant possesses a nanocrystalline structure that allows vascularization and the necessary exchange of biological fluids to support bone regeneration.

Visit website.

Stefano Di Lullo
flag
Stefano Di Lullo, CEO
GreenBone Ortho

In-Person Presenter
RevBio

RevBio is using tetranite, a unique organic compound, as the base for its platform of bone adhesive biomaterials. The company's proprietary biomaterial is capable of multi-surface bonding, rapidly reaching mechanical stability, performing well in wet fields, and biodegrading at a controlled rate. RevBio's tetranite is under investigation for use in dental, cranial, trauma, spine, and animal health markets, with additional expansion opportunities identified.

Visit website.

Brian Hess
flag
Brian Hess, CEO & Founder
RevBio

In-Person Presenter
AnchorValve

AnchorValve is developing an innovative solution that addresses the limitations of current solutions for transcatheter mitral valve replacement (TMVR) and tricuspid valve replacement (TTVR). The company is developing a two-step device that is delivered transeptally, which consists of docking platform anchors that firmly anchor the valve to minimize para-device leakage and a valved stent. Unlike conventional devices, which are placed deep inside the left ventricle, AnchorValve's solution is positioned between the left atrium and ventricle - allowing the valve leaflets to move freely, with reduced need for lifetime anticoagulation therapy.

Visit webiste.

Eric Berreklouw
flag
Eric Berreklouw, Founder & CMO
AnchorValve

In-Person Presenter
WISE

WISE's competitive advantage is built on a proprietary technology, Supersonic Technology, that allows for the insertion of electronic microcircuits in biocompatible silicones. WISE's lead product, the WISE Cortical Strip, is a single-use medical device for intraoperative neurophysiological monitoring during brain tumor and epilepsy surgeries. In addition, the company is developing the Heron lead, an expandable percutaneous paddle lead for spinal cord stimulation.

Visit website.

Luca Ravagnan
flag
Luca Ravagnan, CEO & Co-Founder
WISE

In-Person Presenter
Xenter

Xenter is focused on developing new wireless medical device and giital technologies for interventional cardiology, radiology, and neurointerventional radiology. At the core of the company's technology is Physical Intelligence, which gives healthcare providers real-time in-vivo data to solve acute issues and produce durable results. 

Visit website.

Rich Linder
flag
Rich Linder, CEO & Chairman
Xenter

In-Person Presenter booth icon Innovator Pavilion
Orixha

Orixha's LunoLIVE platform uses the lungs as a thermal bio-exchanger to continuously and precisely adjust a patient's blood and body temperature. The technology produces a hypothermic effect and protect the brain, heart and kidneys from the inflammatory cytokine storm that occurs in cardiac arrest patients. 

Visit website.

Fabrice Paublant
flag
Fabrice Paublant, CEO & Co-Founder
Orixha

In-Person Presenter
Tada Medical AB

Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy. 

Visit website.

Katarina Hedbeck
flag
Katarina Hedbeck, CEO & Co-Founder
Tada Medical AB

In-Person Presenter
Biomedical Bonding AB

Biomedical Bonding aims to introduce the next generation of solutions for fracture and bone restoration. The company is developing a medical adhesive and composite platform technology for hard and soft tissue indications. Biomedical Bonding's lead product, Bonevolent Adhfix, is a biomaterial solution that overcomes the challenges of current therapies for bone fractures by adapting to any bone shape without the need for metal plates.

Visit website.elina Mikaelson has an M.Sc. from Uppsala University in business, economics, and law and she has extensive experience and excellent track record regarding management, business development, sales and profit improvements from previous positions as Head of Business for various companies and business units within the Adlibris group.  Most recently she holds an executive position within explorative digital development and innovation at The Agency for digital Government.isit 

Evelina Mikaelson
flag
Evelina Mikaelson, CEO
Biomedical Bonding AB

In-Person Presenter
Kenota Health

Kenota Health is developing a point-of-care diagnostic solution to simplify allergy testing. The company's lead product is a rapid system that utilizes a small blood sample to test patient's allergic sensitizations in the clinic in under 30 minutes. 

Visit website.

Moufeed Kaddoura
flag
Moufeed Kaddoura, CEO
Kenota Health

In-Person Presenter
Vitestro

Vitestro is developing an autonomous platform for drawing blood. The company's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion to insure accurate and secure blood collection. 

Visit website.

Toon Overbeeke
flag
Toon Overbeeke, Co-Founder & CEO
Vitestro

In-Person Presenter
Sensome

Sensome is developing an innovative remote and non-invasive monitoring system for implantable medical devices allowing the characterization of the tissue surrounding the device. The company's sensing technology combines impedance-based micro-sensors with machine learning algorithms to identify biological tissues upon contact. The lead application for Sensome's technology is the Clotild connected guidewire for the treatment of ischemic stroke. 

Visit website.

Franz Bozsak
flag
Franz Bozsak, CEO
Sensome

In-Person Presenter
NeuraLace Medical

NeuraLace Medical are the developer's of Axon Therapy, an FDA-cleared solution for the management of chronic pain. Axon Therapy uses noninvasive, magnetic pulse technology to treat chronic nerve pain in patients recovery from injury or surgical procedures.

Visit website.

Keith Warner
flag
Keith Warner, CEO
NeuraLace Medical

In-Person Presenter
Healium Medical

Healium medical is focused on advancing atrial fibrillation treatment with an innovative, no-contact guided ablation technology that allows simultaneous tissue ablation and lesion monitoring. The company's Echomplish platform features miniature transcatheter ultrasound technology to deliver precise ultrasonic energy for safe and rapid lesion formation. 

Visit website.

Ran Sela
flag
Ran Sela, CEO
Healium Medical

In-Person Presenter
FibroBiologics

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells. The company's pipeline currently consists of multiple fibroblast cell-based therapies for degenerative disc disease, multiple sclerosis, wound healing and other chronic diseases.

Visit website.

Pete O'Heeron
flag
Pete O'Heeron, Chairman, CEO, & Founder
FibroBiologics

In-Person Presenter
Otivio

Otivio is a medical device company based in Oslo, Norway. Our vision is to stimulate active self care and treatment through simple and easy to use home treatment devices and services. We plan to launch our product, FlowOx, for treatment of Multiple Sclerosis Spasticity Symptoms in Scandinavia in first quarter 2024.

Visit website.

Andreas Mollatt
flag
Andreas Mollatt, CEO
Otivio

In-Person Presenter
Arsenal Medical

Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage. 

Visit website.

Upma Sharma
flag
Upma Sharma, President & CEO
Arsenal Medical

In-Person Presenter
MEXBRAIN

MexBrain is developing a novel technology to remove free metals from the blood. The company's technology combines dialysis and nanotechnology to restore metal homeostasis in patients with Acute Kidney Injury and Wilson's disease.

Visit website.

Thomas Brichart
flag
Thomas Brichart, CEO
MEXBRAIN

In-Person Presenter
Ceretrieve

Ceretrieve is developing CathTrap, a uniquely designed aspiration catheter that offers improved handling, enhanced clot aspiration, and improved retention of clots during removal. CathTrap features a proprietary large bore funnel and closure tip to securely remove clots in ischemic stroke cases. 

Visit website.

Maysa Mustafa
flag
Maysa Mustafa, CEO
Ceretrieve

In-Person Presenter
Augmedit

Augmedit develops augmented reality tools to empower physicians and inform patients. Lumi is a platform of technologies intended to create 3D visualizations of medical images into interactive AR models for pre- and peri-operative use. Currently the company is focused on applying its core technology to neurosurgery, with plans to take their technology beyond the head in the future.

Visit website.

Claartje Ypma
flag
Claartje Ypma, CEO
Augmedit

In-Person Presenter
e-Scopics

e-Scopics is democratizing ultrasound imaging for all healthcare professionals. The company manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer hardware based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis. 

Visit website.

Claude Cohen-Bacrie
flag
Claude Cohen-Bacrie, Founder & CEO
e-Scopics

In-Person Presenter booth icon Innovator Pavilion
VESTECK

VESTECK Suture-Tight catheter secures endovascular aortic grafts to the aorta at the time of implant or during repair procedures.

Visit website.

Joseph Rafferty
flag
Joseph Rafferty, CEO
VESTECK

In-Person Presenter
Sharpview Ophthalmology

SharpView Ophthalmology is committed to developing medical technologies in the field of ocular implants for macular disorders. The company's lead product, EyeMax Mono, uses innovative lens technology for patients with dry AMD and cataracts. EyeMaxMono makes it possible for patients to use the functioning areas of the macula that are not as severely affected by disease to improve their vision.

Visit website.

Phil Marron
flag
Phil Marron, COO
Sharpview Ophthalmology

In-Person Presenter
Hypervision Surgical

Hypervision Surgical is developing an AI-driven intraoperative imaging system for wide-field tissue differentiation to identify normal tissue, nerves, blood vessels and tumors in real time. The technology is non-invasive, non-contact and does not require the use of exogenous contrast agent. 

Visit website.

Michael Ebner
flag
Michael Ebner, CEO & Co-Founder
Hypervision Surgical

In-Person Presenter
OrthoSon

OrthoSon's minimally invasive, motion-restoring treatment is being developed as an alternative to spinal fusion for the treatment of degenerated discs. The treatment, which was spun out of the University of Oxford, involves the injection of sonosensitive particles into degenerated disc vertebrae and then activated with ultrasound to perform controlled nucleotomy. Once the degenerated nucleus has been fragmented, a liquid nucleus replacement is injected into the cavity and cured - providing patients with a well integrated prosthetic. The entire procedure replaces a degenerated nucleus pulposus through a single 1.5mm annulus puncture. 

Visit website.

Richard Simmonds
flag
Richard Simmonds, CEO
OrthoSon

In-Person Presenter
Haermonics

Haermonics has developed a novel drainage system to prevent complications in postoperative open-heart surgery patients. The Haermonics Laebroides system continuously flushes and cleans the pericardial space - preventing complications such as unevacuated blood and clots that occur around the heart. 

Visit website.

Wouter Markus
flag
Wouter Markus, CEO
Haermonics

In-Person Presenter
Neuroelectrics

Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG.

Visit website.

Ana Maiques
flag
Ana Maiques, CEO
Neuroelectrics

In-Person Presenter booth icon Innovator Pavilion
InVera Medical

InVera Medical is developing a catheter-based therapy for chronic venous disease.  The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.

Visit website.

Stephen Cox
flag
Stephen Cox, CEO
InVera Medical

In-Person Presenter
Access Vascular

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.

Visit website.

James Biggins
flag
James Biggins, CEO
Access Vascular

In-Person Presenter
SpinaFX Medical

SpinaFX Medical is committed to bridging the therapeutic gap (conservative vs. surgery) in the treatment of back and leg pain caused by a contained herniated disc. The company is pioneering a minimally invasive, image-guided treatment that injects a mixture of oxygen and ozone gas to reduce herniated disc volume. Animal studies and mathematical modeling have shown that a reduction in disc volume can lead to reduced pressure, thereby relieving nerve root compression and herniated disc-related pain.

Visit website.

Jeff Cambra
flag
Jeff Cambra, CEO
SpinaFX Medical

In-Person Presenter
BMD

Novel medical devices to enhance the reliability and safety of orthopedics procedures. 

Visit website.

Kambiz Behzadi
flag
Kambiz Behzadi, President
BMD

In-Person Presenter
Positrigo

Positrigo is developing a functional positron emission tomography (PET) system with a small footprint at a fraction of the cost of current PET scanners. The company's NeuroLF system is an ultra-compact, dedicated PET system for the brain.

Visit website.

Jannis Fischer
flag
Jannis Fischer, CEO
Positrigo

In-Person Presenter
Trukera Medical

Trukera Medical is building a portfolio of products to address unmet needs in eye care for patients and providers. The company's ScoutPro osmolarity system is a handheld osmolarity testing device for the detection of toxic hyperosmolarity, a condition which damages corneal cells and drives refractive instability. 

Visit website.

Adam Szaronos
flag
Adam Szaronos, CEO
Trukera Medical

In-Person Presenter
Medical 21

Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.

Visit website.

Manny Villafaña, PhD, Sc
flag
Manny Villafaña, PhD, Sc, Founder of St. Jude Medical, ATS, Cardiac Pacemakers
Medical 21

In-Person Presenter
McGinley Orthopedics

The IntelliSense Drill is an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.

Visit website.

Joseph McGinley
flag
Joseph McGinley, Founder & CEO
McGinley Orthopedics

In-Person Presenter booth icon Innovator Pavilion
Agile Devices

Agile Devices is a medical device development company dedicated to the invention and realization of innovative steerable and deflectable catheter technologies that reduce procedure time, cost, and risk. With a focus on interventional radiology, cardiology and neuroradiology, Agile Devices' Angler Microcatheter features novel coaxial deflection technologies to make interventions cost-effective, faster, and safer.

Visit website.

Benjamin Merewitz
flag
Benjamin Merewitz, Co-founder & CEO
Agile Devices

In-Person Presenter booth icon Innovator Pavilion
Medinbox

Medinbox has developed a real-time, smart collaboration solution for use in the operating room and cathlab. The technology is designed to be easily operated and seamlessly integrate into the existing medical environment. Medinbox can utilize up to 16 imaging inputs to open up the OR for remote proctoring, support, and training & education. The company's solution is intended to simplify recording, live streaming, and collaboration.

Visit website.

Nicolas Gausserand
flag
Nicolas Gausserand, Co-Founder & CEO
Medinbox

booth icon Innovator Pavilion
CorNeat Vision

CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery. 

Visit website.

Almog Aley-Raz
flag
Almog Aley-Raz, CEO & VP R&D
CorNeat Vision

In-Person Presenter booth icon Innovator Pavilion
Solenic Medical

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.

Visit website.

James Lancaster
flag
James Lancaster, CEO
Solenic Medical

In-Person Presenter
Field Medical

Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, and electromagnetic localization mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy. 

Visit website.

Steven Mickelsen
flag
Steven Mickelsen, CEO
Field Medical

In-Person Presenter booth icon Innovator Pavilion
Vascular Perfusion Solutions

Vascular Perfusion Solutions specializes in the development of technologies to enhance the preservation of organs. The VP.S ENCORE device is designed to extend the viability of organs for transplantation beyond the current standard of care. The device consists of a single-use disposable unit that operates with a non-blood, nutrient-rich solution. VPS is currently focused on developing the device for use in heart transplantation, with plans to modify the device for the preservation of other organs, ex vivo therapies, and organ banking. 

Visit website.

Rafael J. Veraza
flag
Rafael J. Veraza, CEO & President
Vascular Perfusion Solutions

In-Person Presenter
CVAC Systems

Cyclic Variations in Altitude Conditioning (CVAC) is a is an effort-free method for physical conditioning for individuals of all ages and activity levels to improve fitness. The CVAC process applies precisely composed rhythm-based changes to pressure, temperature and density of air to create waves of tension and relaxation. These changes simulate breathing, muscle contraction, and blow flow changes consistent with circuit, interval and strength training. 

Visit website.

Allen Ruszkowski
flag
Allen Ruszkowski, President & CEO
CVAC Systems

booth icon Innovator Pavilion
NovaResp Technologies
NovaResp has developed a patented software compatible with any positive airway pressure (PAP) machine to dramatically improve comfort and adherence to therapy for obstructive sleep apnea (OSA) patients. The company's platform software uses artificial intelligence and machine learning during PAP therapy to predict and prevent episodes of apnea before they would occur. As a result, personalized therapy can be delivered via PAP machines at lower, more comfortable air pressure levels. 

Visit website.

Hamed Hanafi
flag
Hamed Hanafi, President & CEO
NovaResp Technologies

In-Person Presenter
Nurami Medical

Nurami Medical is a developer of soft tissue repair technologies that leverage the company's expertise in brain physiology, nanofibers, and biomaterials. Nurami's technology utilizes a combination of electrospun nanofiber scaffolds and advanced bioactive materials. The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.

Visit website.

Nora Nseir
flag
Nora Nseir, Co-Founder & Co-CEO
Nurami Medical

In-Person Presenter
PRECISIS

EASEE is Precisis' neurostimulation device that can act in two modes - excitatory and inhibitory. The duality of the device allows its to be used for the treatment of many cerebral diseases, including epilepsy, depression, and cognitive disfunctions caused by stroke. Precisis is currently developing a close-loop system for their EASEE technology, which will allow the device to record brain activity and respond with targeted stimulation.

Visit website.

Angela Liedler
flag
Angela Liedler, CEO
PRECISIS

In-Person Presenter
Gyder Surgical

Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.

Visit website.

Sujit Dike
flag
Sujit Dike, CEO
Gyder Surgical

In-Person Presenter
Oxford Endovascular

Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.

Visit website.

Mike Karim
flag
Mike Karim, CEO
Oxford Endovascular

In-Person Presenter
ThinkSono

ThinkSono is democratizing access to ultrasound devices. The company's ThinkSono AI platform uses artificial intelligence to guide and empower training with ultrasound at the point-of-care – allowing non-specialists to rapidly learn how to perform ultrasound examinations. Beyond ultrasound training, the company is developing AutoDVT, an AI-enabled solution that enables healthcare professionals to perform point-of-care scans for Deep Vein Thrombosis using a handheld ultrasound transducer and mobile phone.

Visit website.

Fouad Noor
flag
Fouad Noor, Co-founder & CEO
ThinkSono

In-Person Presenter
StemMedical

StemMedical's mission is to change the paradigm for stem cell therapy. The company's platform is versatile and enables the production of affordable mesenchymal stem cells for clinical and commercial use. The platform isolates a small number of adipose tissue-derived stem/stromal cells and then produces and expands a desirable concentration of MSCs from the initial sample. StemMedical is currently focused on two strategic segments: the cosmetic surgery market and inflammatory conditions. 

Visit website.

Josef Christensen
flag
Josef Christensen, Chief Business Development Officer
StemMedical

In-Person Presenter
QV Bioelectronics

QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumors. The company's technology utilizes Electric Field Therapy to emit specific frequencies of electric fields that disrupt cancer cell growth cycles. The company's first device, GRACE, is an implanted device that delivers Electric Field Therapy to the tumor resection margins in patients with glioblastoma multiforme.

Visit website.

Christopher Bullock
flag
Christopher Bullock, CEO & Co-Founder
QV Bioelectronics

In-Person Presenter
Image Navigation

Image Navigation creates solutions to improve dental care. The company's flagship product, Image Guided Implantology (IGI), utilizes CT scans and presurgical planning to guide dental implant placement. The IGI system is intended to reduce procedure time, support the surgeon, and minimize postoperative morbidity. Image Navigation also offers DentSim - an augmented reality dental simulation to help dental students hone their skills. 

Visit website.

Lawrence Obstfeld
flag
Lawrence Obstfeld, CEO
Image Navigation

In-Person Presenter
ZiO Health

ZiO Health has developed a proprietary, miniaturized technology that brings lab-quality testing to the point-of-care for various single-point and continuous monitoring applications. The technology utilizes artificial intelligence for applications in therapeutic drug monitoring and precision dosing to improve patient drug outcomes. Beyond drug monitoring, the company is evaluating its technology for home-based molecular level testing and consulting and other partnership-based solutions. 

Visit website.

Neel Patel
flag
Neel Patel, Co-Founder & CEO
ZiO Health

In-Person Presenter
Osteal Therapeutics

Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients. 

Visit website.

David Thompson
flag
David Thompson, CEO
Osteal Therapeutics

In-Person Presenter
INNOVENTRIC

Innoventric is developing a reliable, easy-to-use percutaneous solution for treating tricuspid regurgitation. The company's Trillium™ device uses cross-caval anchoring, a unique multi-valve design, and fits a wide range of anatomies without the risks of migration and leaks. The Trillium™ has completed a 20-patient FIH study in Germany, Belgium, and Spain, showing excellent clinical results, with a < 10-minute transcatheter procedure.

Visit website.

Amir Danino
flag
Amir Danino, Founder & CEO
INNOVENTRIC

In-Person Presenter
Moon Surgical

Moon Surgical is developing a surgical robot to assist with laparoscopic surgeries. The system will feature a modular platform, computer vision, and haptics to augment the capabilities of surgeons.  

Visit website.

Jeffery Alvarez
flag
Jeffery Alvarez, Chief Strategy Officer
Moon Surgical

In-Person Presenter
Retia Medical

Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients. Using the data from our monitor, clinicians implement proven protocols that reduce acute kidney injuries, myocardial injuries and other costly complications.

Visit website.

Marc Zemel
flag
Marc Zemel, CEO
Retia Medical

In-Person Presenter
FluidAI Medical

FluidAI is developing smart monitoring solutions to detect anastomotic postoperative complications early. The company's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.

Visit website.

Youssef Helwa
flag
Youssef Helwa, CEO
FluidAI Medical

In-Person Presenter
FundamentalVR

Accelerating surgical capability for life science businesses via precision VR simulation.

Visit website.

Richard Vincent
flag
Richard Vincent, Founder & CEO
FundamentalVR

In-Person Presenter
inHEART

inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.

Visit website.

Todor Jeliaskov
flag
Todor Jeliaskov, Chairman & CEO
inHEART

In-Person Presenter
Radiance Therapeutics

Next-generation beta ophthalmic applicator.

Visit website.

Laurence Marsteller
flag
Laurence Marsteller, CEO
Radiance Therapeutics

In-Person Presenter
Pixium Vision

Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.

Visit website.

Lloyd Diamond
flag
Lloyd Diamond, CEO
Pixium Vision

In-Person Presenter
Alio

Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.

Visit website.

David Kuraguntla
flag
David Kuraguntla, CEO
Alio

In-Person Presenter
Newronika

Newronika is developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease. AlphaDBS interprets the bioelectrical neuronal activity (local field potentials, LFPs) in the brain areas where stimulation is delivered and accordingly adapts moment-by-moment the stimulation to follow patient’s clinical condition. 

Visit website.

Lothar Krinke
flag
Lothar Krinke, CEO
Newronika

In-Person Presenter
Novuson

Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.

Visit website.

Stuart Mitchell
flag
Stuart Mitchell, Founder & CEO
Novuson

In-Person Presenter
Aqua Medical

Treating type 2 diabetes and GI disease with 30 minute, out-patient, endoscopic ablation therapy

Visit website.

Lloyd Mencinger
flag
Lloyd Mencinger, President & CEO
Aqua Medical

In-Person Presenter
TibaRay

TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging. The PHASER system verifies tumor and organ positioning and "freezes" motion as treatment is delivered.

Visit website.

Jeff Amacker
flag
Jeff Amacker, CEO
TibaRay

In-Person Presenter booth icon Innovator Pavilion
Locate Bio

Locate Bio is working to solve some of the most complex degenerative and infectious diseases that affect the muscular skeletal system. Locate utilises Programmed Drug Release to re-align the bioavailability of existing drugs with the underlying biological need. This bio-optimisation step has demonstrated break through improvements in performance in preclinical testing.

Locate Bio’s lead product, LDGraft, is entering human clinical studies next year, for the treatment of chronic lower back pain caused by degenerative disc disease. CognitOss Gel is in developed to overcome bacterial biofilm infections around non-viable tissue and orthopaedic implants.

Visit website.

John von Benecke
flag
John von Benecke, CEO
Locate Bio

In-Person Presenter
CAPS Medical

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. 

Visit website.

Ilan Uchitel
flag
Ilan Uchitel, CEO
CAPS Medical

In-Person Presenter
WHO IS ATTENDING

Companies We Work With